Liraglutide

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5643 publications

Repurposed Drugs and Cardiovascular Morbidity: A Cost-Effectiveness Analysis.

Repurposed Drugs and Cardiovascular Morbidity: A Cost-Effectiveness Analysis.

Journal: American journal of therapeutics

Published: June 24, 2026

Long-term effects of weight-reducing drugs in people with hypertension.

Long-term effects of weight-reducing drugs in people with hypertension.

Journal: The Cochrane database of systematic reviews

Published: June 19, 2026

Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity: A Living Systematic Review and Network Meta-analysis for the American College of Physicians.

Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity: A Living Systematic Review and Network Meta-analysis for the American College of Physicians.

Journal: Annals of internal medicine

Published: June 15, 2026

Pharmacologic Treatments With Lifestyle Modifications in Nonpregnant Adults With Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline From the American College of Physicians (April 2026).

Pharmacologic Treatments With Lifestyle Modifications in Nonpregnant Adults With Overweight or Obesity in Outpatient Settings: A Living Clinical Guideline From the American College of Physicians (April 2026).

Journal: Annals of internal medicine

Published: June 15, 2026

Cost-Effectiveness of Pharmacologic Treatments in Adults With Overweight or Obesity: A Systematic Review for the American College of Physicians.

Cost-Effectiveness of Pharmacologic Treatments in Adults With Overweight or Obesity: A Systematic Review for the American College of Physicians.

Journal: Annals of internal medicine

Published: June 15, 2026

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Journal: Disease-a-month : DM

Published: June 12, 2026

Correction: Protective effects of liraglutide on hypercholesterolemia-associated atherosclerosis involve attenuation of endothelial-monocyte adhesion through down-regulating the LOX-1/NF-κB signaling pathway.

Correction: Protective effects of liraglutide on hypercholesterolemia-associated atherosclerosis involve attenuation of endothelial-monocyte adhesion through down-regulating the LOX-1/NF-κB signaling pathway.

Journal: Scientific reports

Published: June 12, 2026

OCT1 Variants Are Associated with Metformin Clearance and Gluconeogenesis: Mechanistic Insights for Youth-Onset Type 2 Diabetes in the MIGHTY Study.

OCT1 Variants Are Associated with Metformin Clearance and Gluconeogenesis: Mechanistic Insights for Youth-Onset Type 2 Diabetes in the MIGHTY Study.

Journal: medRxiv : the preprint server for health sciences

Published: June 05, 2026

Correction to "Aggregation-driven expression of liraglutide precursors using engineered mini-tags in Escherichia coli".

Correction to "Aggregation-driven expression of liraglutide precursors using engineered mini-tags in Escherichia coli".

Journal: Protein science : a publication of the Protein Society

Published: June 03, 2026

Accounting for non-adherence: A re-analysis of the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results trial.

Accounting for non-adherence: A re-analysis of the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results trial.

Journal: Clinical trials (London, England)

Published: June 02, 2026

GLPs Significantly Decrease the Risk of Postoperative Surgical Complications: A TriNetX Retrospective Cohort Study.

GLPs Significantly Decrease the Risk of Postoperative Surgical Complications: A TriNetX Retrospective Cohort Study.

Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]

Published: May 29, 2026

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Journal: Disease-a-month : DM

Published: May 29, 2026

Showing 1-12 of 5,643

Last Updated: 06/30/2026